Antimicrobial Agents Practice Questions

Q: What is the single dose treatment for chlamydia?

Azithromycin. **Explanation:** The correct answer is **Azithromycin**. **1. Why Azithromycin is correct:** Azithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit. For uncomplicated genital *Chlamydia trachomatis* infections, a **single oral dose of 1 gram** is highly effective [1]. Its long half-life and excellent tissue penetration allow for a single-dose regimen, which ensures 100% patient compliance—a critical factor in treating sexually transmitted infections (STIs). **2. Why the other options are incorrect:** * **Doxycycline:** While Doxycycline is considered a first-line treatment for Chlamydia (and often preferred in recent CDC guidelines for rectal infections), it is **not a single-dose treatment**. It requires a 100 mg twice-daily regimen for **7 days**. * **Tetracycline:** This is an older generation drug with a shorter half-life and more side effects compared to Doxycycline. It requires multiple daily doses for 7 days and is rarely used now. * **Erythromycin:** This is typically reserved as an alternative for pregnant patients who cannot tolerate Azithromycin. It requires a 7-day course and is associated with significant gastrointestinal upset. **Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) in Pregnancy:** Azithromycin (1g single dose) is the DOC for Chlamydia in pregnant women. * **Syndromic Management (WHO/NACO):** For Urethral Discharge (Grey Kit), the treatment includes **Azithromycin 1g (stat)** plus **Cefixime 400mg (stat)** to cover both Chlamydia and Gonorrhea. * **Lymphogranuloma Venereum (LGV):** Caused by L1, L2, L3 serovars of Chlamydia; the treatment is Doxycycline for **21 days**, not a single dose. * **Partner Management:** Always treat the sexual partner(s) to prevent reinfection ("ping-pong" infection).

Q: Which of the following drugs cannot be used to treat Candida infection?

Griseofulvin. **Explanation:** The correct answer is **Griseofulvin** because of its specific spectrum of activity and mechanism of action. **1. Why Griseofulvin is the correct answer:** Griseofulvin is a fungistatic drug that acts by binding to fungal microtubules, thereby inhibiting mitosis. Its clinical utility is strictly limited to **Dermatophytosis** (infections caused by *Trichophyton, Epidermophyton,* and *Microsporum*). It has **no activity** against *Candida* species or deep systemic mycoses. It is unique because it deposits in keratin precursor cells, making them resistant to fungal invasion. **2. Why the other options are incorrect:** * **Ketoconazole (Option A):** An imidazole derivative that inhibits ergosterol synthesis. It is effective against various *Candida* species, though its systemic use has largely been replaced by safer triazoles (like Fluconazole). * **Nystatin (Option B):** A polyene antibiotic similar to Amphotericin B. It is too toxic for systemic use but is a first-line agent for **topical or oral candidiasis** (thrush). * **Amphotericin B (Option C):** The "gold standard" polyene for systemic fungal infections. It binds to ergosterol in the fungal cell membrane, creating pores. It is highly effective against most *Candida* species, including those causing invasive candidemia. **High-Yield Clinical Pearls for NEET-PG:** * **Griseofulvin** is a potent **Microsomal Enzyme Inducer** (decreases Warfarin efficacy) and can trigger **disulfiram-like reactions**. * **Drug of Choice (DOC) for Candidiasis:** Fluconazole is the DOC for most localized infections; Echinocandins (e.g., Caspofungin) are often preferred for systemic candidemia in unstable patients. * **Griseofulvin** absorption is significantly increased when taken with a **fatty meal**.

Q: Which of the following drugs is not used in the treatment of Mycobacterium avium intracellular infection?

Eflornithine. **Explanation:** The treatment of *Mycobacterium avium-intracellulare* complex (MAC) requires a multidrug regimen due to its high level of intrinsic resistance to standard antitubercular drugs. **Why Eflornithine is the correct answer:** **Eflornithine** is an antiprotozoal medication, not an antimycobacterial agent. It acts as an irreversible inhibitor of ornithine decarboxylase. Its primary clinical uses include the treatment of **African Trypanosomiasis** (Sleeping Sickness caused by *Trypanosoma brucei gambiense*) and topically to reduce unwanted facial hair (hirsutism) in women. It has no activity against MAC. **Analysis of Incorrect Options:** * **Clarithromycin (Option A):** Macrolides (Clarithromycin or Azithromycin) are the **backbone** of MAC therapy. They are used for both prophylaxis (in HIV patients with CD4 <50 cells/mm³) and active treatment. * **Ethambutol (Option C):** This is a standard component of the multidrug regimen for MAC. It is added to a macrolide to enhance efficacy and prevent the emergence of drug resistance. * **Rifabutin (Option D):** Rifabutin is preferred over Rifampin for MAC because it is more potent against the complex and has fewer drug-drug interactions with antiretroviral therapy (ART) in HIV patients. **High-Yield Clinical Pearls for NEET-PG:** * **Standard MAC Regimen:** Clarithromycin + Ethambutol + Rifabutin. * **Prophylaxis:** Indicated in HIV patients when CD4 count falls below **50 cells/mm³**. * **Eflornithine Mnemonic:** "Resurrection drug" for African Sleeping Sickness (coma stage). * **Rifabutin Side Effect:** Watch for **uveitis** and orange discoloration of secretions.

Q: Which of the following antimalarial drugs possesses immunomodulatory effects?

Hydroxychloroquine. **Explanation:** The correct answer is **Hydroxychloroquine (HCQ)**. While both Chloroquine and Hydroxychloroquine are 4-aminoquinolines, HCQ is specifically recognized for its potent **immunomodulatory properties** in addition to its antimalarial action. **Why Hydroxychloroquine is correct:** HCQ acts as a weak base that accumulates in intracellular lysosomes, increasing the pH. This interferes with antigen processing and inhibits the stimulation of **Toll-like receptors (TLRs)**, specifically TLR-7 and TLR-9. This leads to a decrease in the production of pro-inflammatory cytokines like Type 1 Interferons, TNF-α, and IL-6. Due to this mechanism, HCQ is a first-line **Disease-Modifying Anti-Rheumatic Drug (DMARD)** used in systemic lupus erythematosus (SLE) and rheumatoid arthritis. **Why other options are incorrect:** * **Chloroquine:** Although it has some anti-inflammatory properties, it is significantly more toxic (especially ocular toxicity) than HCQ. In modern clinical practice, the term "immunomodulator" in this class almost exclusively refers to HCQ due to its superior safety profile for long-term autoimmune therapy. * **Quinine:** This is a cinchona alkaloid used primarily for severe malaria or chloroquine-resistant cases. It lacks significant immunomodulatory effects and is known for its narrow therapeutic index (Cinchonism). **High-Yield NEET-PG Pearls:** * **Ocular Toxicity:** Both drugs cause "Bull’s eye maculopathy," but the risk is significantly lower with HCQ (safe dose <5mg/kg/day). * **Drug of Choice:** HCQ is the DOC for maintaining remission in **SLE** and is safe during pregnancy for SLE patients. * **Side Effects:** Watch for QTc prolongation and hemolysis in G6PD-deficient patients.

Q: Primaquine acts on which stage of the life cycle of all human malarial parasites for causal prophylaxis?

Pre-erythrocytic. **Explanation:** The correct answer is **Pre-erythrocytic (Option A)**. **1. Why Pre-erythrocytic is correct:** In the context of malaria, **Causal Prophylaxis** refers to the prevention of infection by killing the parasite in the liver *before* it enters the bloodstream (erythrocytic stage). Primaquine is unique because it is effective against the primary **pre-erythrocytic (hepatic) stages** of all human malarial parasites, including *P. falciparum* and *P. vivax*. By destroying the schizonts in the liver, it prevents the initiation of the erythrocytic cycle and clinical illness. **2. Why the other options are incorrect:** * **B. Erythrocytic:** Drugs acting here provide "Suppressive Prophylaxis" (e.g., Chloroquine). Primaquine has very weak activity against asexual blood stages and cannot be used to treat an acute clinical attack. * **C. Exo-erythrocytic:** While Primaquine acts on liver stages, "Exo-erythrocytic" is a broader term. In NEET-PG, "Causal Prophylaxis" specifically maps to the **Pre-erythrocytic** stage. * **D. Hypnozoite:** Primaquine does kill hypnozoites (latent liver stages of *P. vivax/ovale*), but this action is termed **Radical Cure**, not causal prophylaxis. **3. NEET-PG High-Yield Pearls:** * **G6PD Deficiency:** Always screen patients for G6PD levels before prescribing Primaquine, as it can cause severe **acute hemolytic anemia**. * **Pregnancy:** Primaquine is **contraindicated** in pregnancy because the fetus is relatively G6PD deficient. * **Gametocidal Action:** Primaquine is the drug of choice for killing gametocytes of all species (including *P. falciparum*), thereby preventing the transmission of malaria to mosquitoes. * **Tafenoquine:** A newer long-acting analog of Primaquine used for the same indications.

Q: All of the following statements about Voriconazole are true EXCEPT:

It is the only azole used in the treatment of mucormycosis.. **Explanation:** This question tests your knowledge of the spectrum and side-effect profile of triazole antifungals. **Why Option D is the Correct Answer (The False Statement):** Voriconazole has **no activity** against the *Mucorales* species. In fact, its use has been associated with an increased incidence of breakthrough mucormycosis in immunocompromised patients. The azoles effective against Mucormycosis are **Posaconazole** and **Isavuconazole**. The primary treatment for mucormycosis remains Liposomal Amphotericin B. **Analysis of Incorrect Options (True Statements):** * **Option A:** Voriconazole is indeed the **Drug of Choice (DOC)** for invasive aspergillosis, having shown superior efficacy and better survival rates compared to Amphotericin B. * **Option B:** A unique side effect of Voriconazole is **transient visual disturbances** (photopsia, blurred vision, or altered color perception), occurring in about 30% of patients shortly after dosing. * **Option C:** Like most azoles, Voriconazole can cause **QT interval prolongation**, necessitating caution when co-administered with other drugs that affect cardiac conduction (e.g., quinidine, terfenadine). **High-Yield Clinical Pearls for NEET-PG:** 1. **Metabolism:** Voriconazole follows **non-linear kinetics** (elimination is saturable). 2. **Dermatological Link:** Chronic use is associated with **photosensitivity** and an increased risk of **squamous cell carcinoma** of the skin. 3. **Spectrum Mnemonic:** Voriconazole = "Vori-Very good for Aspergillus," but "Zero for Mucor." 4. **Monitoring:** It is a potent inhibitor of CYP3A4; always check for drug-drug interactions.

Q: A potent inhibitor of beta-lactamase is:

Clavulanic acid. ### Explanation **Correct Option: B. Clavulanic acid** Clavulanic acid is a **suicide inhibitor** of beta-lactamase enzymes. Structurally, it is a beta-lactam molecule with negligible intrinsic antibacterial activity. However, it binds irreversibly to the active site of the beta-lactamase enzyme produced by bacteria (like *S. aureus*, *H. influenzae*, and *E. coli*). By "sacrificing" itself to neutralize the enzyme, it prevents the destruction of co-administered penicillins, thereby restoring their spectrum of activity. Common combinations include Amoxicillin + Clavulanic acid (Co-amoxiclav). **Analysis of Incorrect Options:** * **A. Carbenicillin:** This is an antipseudomonal penicillin. While it is resistant to some enzymes, it is actually a *substrate* for many beta-lactamases, not an inhibitor. * **C. Cefamandole:** A second-generation cephalosporin. It is known for its methylthiotetrazole (MTT) side chain, which can cause disulfiram-like reactions and hypoprothrombinemia, but it does not inhibit beta-lactamase. * **D. Idoxuridine:** An antiviral agent (pyrimidine analogue) used topically for Herpes Simplex Keratitis. It has no role in bacterial cell wall synthesis or enzyme inhibition. **NEET-PG High-Yield Pearls:** * **Other Beta-lactamase Inhibitors (BLIs):** Sulbactam, Tazobactam, and the newer non-beta-lactam inhibitors like **Avibactam** and **Relebactam**. * **Mechanism:** They are called "suicide inhibitors" because they are chemically modified by the enzyme during the process of inhibition. * **Spectrum:** Clavulanic acid is effective against Ambler Class A beta-lactamases (plasmid-encoded) but is generally ineffective against Class C (AmpC) or Class B (Metallo-beta-lactamases). * **Clinical Note:** The most common side effect of Clavulanic acid is diarrhea (due to increased gut motility).

Q: Metronidazole is effective in all of the following conditions except?

Neurocysticercosis. **Explanation:** **Metronidazole** is a nitroimidazole derivative that acts as a potent **anaerobicidal** and **antiprotozoal** agent [2]. Its mechanism involves the intracellular reduction of its nitro group to form reactive radicals that damage microbial DNA [1]. **Why Neurocysticercosis is the correct answer:** Neurocysticercosis is caused by the larval stage of the pork tapeworm, *Taenia solium*. This is a helminthic infection, not an anaerobic or protozoal one. The drugs of choice for neurocysticercosis are **Albendazole** or **Praziquantel**, often administered with corticosteroids to manage the inflammatory response. Metronidazole has no activity against cestodes (tapeworms). **Analysis of incorrect options:** * **Pseudomembranous colitis:** Caused by *Clostridioides difficile* (an anaerobe). Metronidazole was traditionally the first-line treatment, though oral Vancomycin or Fidaxomicin are now preferred in many guidelines [2]. * **Giardiasis:** Metronidazole is a highly effective treatment for infections caused by the protozoan *Giardia lamblia* [1]. * **Amebic liver abscess:** Metronidazole is the drug of choice for invasive amoebiasis (caused by *Entamoeba histolytica*), including liver abscesses and intestinal wall invasion [1], [4]. **NEET-PG High-Yield Pearls:** * **Spectrum:** Remember the mnemonic **"GET GAP"** for Metronidazole: **G**iardia, **E**ntamoeba, **T**richomonas, **G**ardnerella, **A**naerobes (*B. fragilis*, *C. diff*), and **P**ylori (*H. pylori*) [2]. * **Side Effects:** Metallic taste, furry tongue, and a significant **Disulfiram-like reaction** with alcohol. * **Drug of Choice:** It remains the gold standard for **Bacterial Vaginosis** and **Trichomoniasis** [3].

Q: Which of the following drugs is not used in the treatment of avian influenza?

Ribavirin. **Explanation:** The treatment of Avian Influenza (Bird Flu), primarily caused by strains like H5N1 and H7N9, focuses on **Neuraminidase Inhibitors**. **Why Ribavirin is the correct answer:** Ribavirin is a broad-spectrum antiviral that inhibits RNA polymerase and is primarily used for **Hepatitis C** (in combination with interferon) and **Respiratory Syncytial Virus (RSV)** in children. While it has some *in vitro* activity against influenza, it is **not** a standard of care or clinically recommended treatment for avian influenza. **Why the other options are incorrect:** * **Oseltamivir (Option A):** The drug of choice for both seasonal and avian influenza. It is an oral neuraminidase inhibitor that prevents the release of new virions from infected cells. * **Zanamivir (Option C):** An inhaled neuraminidase inhibitor effective against avian influenza. It is a preferred alternative, especially in cases of suspected oseltamivir resistance. * **Peramivir (Option D):** An intravenous neuraminidase inhibitor used for acute uncomplicated influenza and severe cases where oral or inhaled routes are not feasible. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism of Action:** Neuraminidase inhibitors (Oseltamivir, Zanamivir, Peramivir) work by preventing the cleavage of sialic acid residues, thereby trapping the virus within the host cell. 2. **Timing:** These drugs are most effective when started within **48 hours** of symptom onset. 3. **Baloxavir Marboxil:** A newer drug for influenza that inhibits **cap-dependent endonuclease**, blocking viral mRNA synthesis (single-dose therapy). 4. **Amantadine/Rimantadine:** These M2 ion channel blockers are no longer recommended for influenza due to widespread resistance.

Q: Which anti-tuberculosis drug can cause an eye defect?

Ethambutol. **Explanation:** **Ethambutol (Option A)** is the correct answer because its most characteristic and dose-dependent side effect is **Retrobulbar Neuritis**. This condition typically manifests as a decrease in visual acuity, central scotomas, and a loss of **red-green color discrimination**. The underlying mechanism involves the chelation of copper, which interferes with mitochondrial function in the optic nerve. Because of this risk, patients starting Ethambutol should undergo a baseline visual acuity and color vision test (Snellen and Ishihara charts). **Why other options are incorrect:** * **Pyrazinamide (Option B):** Its most significant side effects are hepatotoxicity and **hyperuricemia** (which can precipitate acute gouty arthritis) by inhibiting the renal excretion of uric acid. * **Rifampicin (Option C):** Known for causing a harmless **orange-red discoloration** of body fluids (urine, sweat, tears). Its serious side effects include hepatotoxicity and a "flu-like syndrome" with intermittent dosing. * **Isoniazid (Option D):** The hallmark side effects are **Peripheral Neuropathy** (due to Vitamin B6/Pyridoxine deficiency) and hepatotoxicity. It does not typically cause optic nerve defects. **High-Yield Clinical Pearls for NEET-PG:** * **Ethambutol** is the only bacteriostatic drug among the first-line ATT (RIPE). * It is contraindicated in children who are too young to undergo reliable visual testing. * **Mnemonic for Ethambutol:** "**E**" for "**E**ye" (Optic neuritis) and "**E**" for "**E**xcretion" (primarily renal; requires dose adjustment in renal failure). * **Visual changes** are usually reversible if the drug is discontinued promptly.

Question 1

What is the single dose treatment for chlamydia?

Accepted Answer

Azithromycin

Answer

Doxycycline

Answer

Tetracycline

Answer

Erythromycin

Question 2

Which of the following drugs cannot be used to treat Candida infection?

Accepted Answer

Griseofulvin

Answer

Ketoconazole

Answer

Nystatin

Answer

Amphotericin

Question 3

Which of the following drugs is not used in the treatment of Mycobacterium avium intracellular infection?

Accepted Answer

Eflornithine

Answer

Clarithromycin

Answer

Ethambutol

Answer

Rifabutin

Question 4

Which of the following antimalarial drugs possesses immunomodulatory effects?

Accepted Answer

Hydroxychloroquine

Answer

Chloroquine

Answer

Quinine

Answer

All of the above

Question 5

Primaquine acts on which stage of the life cycle of all human malarial parasites for causal prophylaxis?

Accepted Answer

Pre-erythrocytic

Answer

Erythrocytic

Answer

Exo-erythrocytic

Answer

Hypnozoite

Question 6

All of the following statements about Voriconazole are true EXCEPT:

Accepted Answer

It is the only azole used in the treatment of mucormycosis.

Answer

It is the drug of choice for invasive aspergillosis.

Answer

It can cause visual disturbances.

Answer

It can also lead to QT prolongation.

Question 7

A potent inhibitor of beta-lactamase is:

Accepted Answer

Clavulanic acid

Answer

Carbenicillin

Answer

Cefamandole

Answer

Idoxuridine

Question 8

Metronidazole is effective in all of the following conditions except?

Accepted Answer

Neurocysticercosis

Answer

Pseudomembranous colitis

Answer

Giardiasis

Answer

Amebic liver abscess

Question 9

Which of the following drugs is not used in the treatment of avian influenza?

Accepted Answer

Ribavirin

Answer

Oseltamivir

Answer

Zanamivir

Answer

Peramivir

Question 10

Which anti-tuberculosis drug can cause an eye defect?

Accepted Answer

Ethambutol

Answer

Pyrazinamide

Answer

Rifampicin

Answer

Isoniazid

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?